Vivimed Labs announced unaudited Q2 FY26 results and board approval to pursue a pre-pack insolvency filing under the IBC, subject to shareholder approval, with trading suspension expected to be lifted in a few days.
AI Assistant
Vivimed Labs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.